Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Rauwolscine, also known as alpha-yohimbine, is an alkaloid structurally related to yohimbine and is found in various plants, including Rauwolfia and Pausinystalia species. Its use to support or treat poor fat metabolism is primarily based on its action as an alpha-2 adrenergic receptor antagonist. Theoretically, by blocking alpha-2 receptors in fat cells, rauwolscine may promote the release of norepinephrine, which can stimulate lipolysis (the breakdown of fat) and potentially enhance fat loss, especially in stubborn fat areas.

However, while there are a few animal and in vitro studies indicating that alpha-2 antagonists can affect fat metabolism, direct clinical evidence in humans for rauwolscine's effectiveness as a fat-loss agent is very limited. Most of the scientific understanding is extrapolated from the better-studied yohimbine, which shares a similar mechanism of action and has shown mild effects on fat loss in certain studies, particularly in athletes or those following calorie-restricted diets. Human trials specifically investigating rauwolscine for fat metabolism are lacking, and the available data are not robust enough to draw firm conclusions about its efficacy or safety for this purpose.

In summary, while the rationale for using rauwolscine to support fat metabolism is grounded in its pharmacological action and some scientific reasoning, the direct evidence is weak and mostly indirect; thus, the level of scientific validation is low.

More about Rauwolscine
More about Fat Metabolism (poor)

Other ingredients used for Fat Metabolism (poor)

Other health conditions supported by Rauwolscine

Products containing Rauwolscine